Loading people...
Diego Rey is the Chief Executive Officer of Gemini Therapeutics and an angel investor at Endpoint Ventures, based in San Francisco, California. He previously co-founded and served as Chief Technology Officer of GeneWEAVE Biosciences, a molecular diagnostics company that was acquired by Roche for up to $425 million. While at GeneWEAVE, he invented the company's core diagnostic technology and secured 27 issued patents before co-founding Endpoint Health as Chief Scientific Officer and Board Director. Rey subsequently served as the first Visiting Partner dedicated to life sciences and healthcare at Y Combinator, where he mentored early-stage biotech startups. He holds a doctorate in Biomedical Engineering from Cornell University and a bachelor's degree in Electrical Engineering from UC Santa Barbara. His professional background centers on translating complex scientific innovations into commercial therapeutics and rapid diagnostic medical devices.
Diego Rey stands out as a prominent Angel investor, bringing his expertise and strategic vision to Endpoint Ventures. In his role, Diego is dedicated to identifying and nurturing the next wave of groundbreaking companies, primarily focusing on early-stage investments. His keen eye for innovation and deep understanding of market dynamics make him a sought-after partner for nascent startups aiming for significant growth.
Diego's investment thesis at Endpoint Ventures is broad yet discerning, encompassing sectors ripe for disruption. He actively seeks opportunities in areas such as artificial intelligence, SaaS platforms, B2B solutions, fintech, and healthcare technology. What truly distinguishes his approach is not just capital deployment, but also the hands-on mentorship and strategic guidance he provides to founders. He believes in building strong relationships with entrepreneurs, offering insights derived from his extensive experience to help navigate the challenges of early-stage development and market entry.
Before dedicating his efforts to angel investing with Endpoint Ventures, Diego Rey cultivated a distinguished career marked by entrepreneurial success and operational leadership. He previously held significant roles within high-growth technology companies, where he was instrumental in scaling operations and driving product innovation. This background equipped him with invaluable first-hand experience in building and expanding ventures from the ground up, giving him a unique perspective on the operational realities and strategic imperatives faced by startups. His journey from operator to investor allows him to offer practical, actionable advice that resonates deeply with founders.
While specific portfolio companies are often kept confidential in the early stages, Diego Rey has built a diverse portfolio of promising startups that are poised to make a substantial impact in their respective industries. His commitment extends beyond financial backing; he is a true partner who leverages his network and knowledge to accelerate the growth and success of his portfolio companies. Through Endpoint Ventures, Diego continues to empower visionary entrepreneurs, helping them transform innovative ideas into market-leading businesses.
Diego Rey is an Angel investor associated with Endpoint Ventures, known for backing early-stage, innovative companies and providing strategic guidance to entrepreneurs.
Diego Rey primarily invests in early-stage companies across various disruptive technology sectors, including AI, SaaS, B2B solutions, fintech, and healthcare technology.
Diego Rey works as an Angel investor with Endpoint Ventures, where he focuses on identifying and supporting promising startups.
